COVID-19 Shots Should Target XBB Variants In Next Vaccination Campaign, FDA Staff Say

Reuters (6/12, Erman, Mishra, Satija) reports, “COVID-19 vaccines being developed and manufactured for the 2023-2024 campaign should target one of the currently dominant XBB variants, the U.S. Food and Drug Administration’s staff reviewers said on Monday....